Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
Sotac Pharmaceuticals Limited logo

Sotac Pharmaceuticals Limited

SOTAC·Pharmaceuticals

Incorporated in 2015, Co. is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis

56Announcements
08-09-2026Last filed
8Last 90 days

What Sotac files

  • Others34
  • Board Meeting7
  • New Orders5
  • Important3
  • Dividend/Bonus3
  • Updates2
Showing New Orders announcements (5)Clear filter
23-07-2026 · 11:54 am

Sotac Pharma secured a Rs. 0.98 Cr purchase order from Intas Pharmaceuticals for finished pharmaceutical formulations. Supplies are scheduled between September and November 2026, bolstering the company's existing order book.

Read the full announcement→
PDF
25-02-2026 · 01:08 pm

Sotac Pharma secured a Rs. 0.49 Cr order from Intas Pharmaceuticals for supplying finished pharmaceutical formulations. Delivery is scheduled between March and May, bolstering Sotac's existing order book.

Read the full announcement→
PDF
11-02-2026 · 04:23 pm

Sotac Pharma secured a Rs 1.39 Cr purchase order from Cadila Pharmaceuticals for various finished pharmaceutical formulations (tablets, capsules, lotions, gels, sprays). Deliveries are scheduled between January and March 2026.

Read the full announcement→
PDF
09-12-2025 · 03:04 pm

Sotac Pharma secured a ~₹1.74 Cr order from Cadila Pharmaceuticals to supply Levozet M Tablets. This contract strengthens their manufacturing capabilities, with deliveries scheduled for January 2026.

Read the full announcement→
PDF
18-11-2025 · 05:43 pm

Sotac Pharmaceuticals secured an order worth approximately Rs 27.64 Cr from Rajasthan Medical Services Corporation. This contract involves the supply of pharmaceuticals, including Diclofenac Gel, with execution expected by March 31, 2027.

Read the full announcement→
PDF